BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 3945450)

  • 21. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL; Russell HT
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

  • 24. [Spontaneous regression of serum HCG in 18 patients following evacuation of uncomplicated androgenic moles].
    Vejerslev LO; Arends J; Larsen SO
    Ugeskr Laeger; 1988 Aug; 150(35):2081-3. PubMed ID: 3413897
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1976 Feb; 47(2):183-8. PubMed ID: 1250540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK; Gokel JM; Holzmann K
    Arch Gynecol; 1979 Jul; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum free estriol and estriol glucuronide fractions in hydatidiform mole measured by radioimmunoassay.
    Dawood MY; Brown JB; Newnam KL
    Obstet Gynecol; 1977 Mar; 49(3):303-7. PubMed ID: 840458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating inhibin forms in patients with hydatidiform mole.
    Kato T; Seki K; Matsui H; Sekiya S
    Gynecol Obstet Invest; 2002; 54(2):114-7. PubMed ID: 12566755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibin: a new circulating marker of hydatidiform mole?
    Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
    BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal human chorionic gonadotropin regression curves in uneventful postmolar patients.
    Kizaki S; Matsui H; Usui H; Shozu M; Hanawa S; Yamamoto E; Kikkawa F
    J Reprod Med; 2012; 57(5-6):243-8. PubMed ID: 22696820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone.
    Soules MR; Hughes CL; Garcia JA; Livengood CH; Prystowsky MR; Alexander E
    Obstet Gynecol; 1980 Jun; 55(6):696-700. PubMed ID: 7383455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines following hydatidiform mole: a reappraisal.
    Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum TSH levels in normal pregnant women and patients with hydatidiform mole and influence of HCG on TSH immunoradiometric assay].
    Hara H; Ban Y; Sato R; Nagakura H; Kushima K; Kaihara M; Matsuzaki H
    Kaku Igaku; 1988 Jan; 25(1):89-96. PubMed ID: 3373811
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum human placental lactogen (HPL) levels in patients with intact hydatidiform mole.
    Lim YC; Chew SC; Ratnam SS
    Acta Obstet Gynecol Scand; 1976; 55(5):407-12. PubMed ID: 187001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
    Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
    Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyroid function and human chorionic gonadotropin in patients with hydatidiform mole.
    Ngowngarmratana S; Sunthornthepvarakul T; Kanchanawat S
    J Med Assoc Thai; 1997 Nov; 80(11):693-9. PubMed ID: 9385765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
    J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.